Detailed Narrative
Q1 FY27 Financial Performance Highlights
Park Medi World Limited reported strong financial results for Q1 FY27, with revenue from operations growing 19% year-on-year to ₹476 crores. Operating EBITDA increased by 20% year-on-year to ₹126 crores, achieving a margin of 26.5%, an improvement from 26.3% in Q1 FY26. Profit After Tax (PAT) saw a significant jump of 35% year-on-year to ₹89 crores, with the PAT margin expanding by 220 basis points to 18.6%.
Strategic Acquisitions and Capacity Expansion
The company continued its aggressive expansion strategy, acquiring 100% shareholding in The Medicity Hospital, Rudrapur (330 beds) for ₹177 crores, which was commissioned on August 2, 2026. Additionally, it announced the acquisition of Mehar Hospital, Zirakpur (150 beds) for ₹107 crores, scheduled to commission in November/December 2026. A 100-bed extension at Palam Vihar (Park Platinum) is also underway. These additions will bring the total bed capacity to 4,740 by end of FY27 and 5,740 by end of FY28.
Operational Metrics and Case Mix Evolution
Operational metrics showed healthy trends, with IPD volumes growing 16% year-on-year to 26,304 patients and OPD volumes up 17% year-on-year to 2,23,446 patients. Average Revenue Per Occupied Bed (ARPOB) increased 12% year-on-year to ₹30,444. The company's focus on high-end tertiary and quaternary care continued, with these specialties contributing approximately 62% of revenue, an increase of 440 basis points year-on-year. Network occupancy for Q1 FY27 stood at 56%, a moderation from 68% in Q1 FY26, attributed to the significant new capacity added over the past 12 months.
FY27 Financial Outlook and Growth Drivers
Management provided robust guidance for FY27, targeting a top-line revenue of ₹2,080 crores (24% YoY growth), EBITDA of ₹530 crores (25% YoY growth), and PAT of ₹360 crores (32% YoY growth). ARPOB growth is expected to remain in the 10-12% band, and blended EBITDA margins are projected to hold at 26.7%-27%. The company anticipates the full impact of CGHS rate revisions (7-7.5% benefit) from Q2 FY27, which will be reinvested into equipment and facility upgrades.
Capital Allocation and Funding Strategy
The company's CAPEX per bed remains competitive at ₹37 lakhs. Total CAPEX planned for FY27 and FY28 is ₹767 crores for 2,130 beds, averaging ₹36 lakhs per bed. This growth plan, including acquisitions and new facility commissioning, is fully funded through internal accruals and IPO proceeds, with no recourse to fresh debt. Net debt (excluding lease liability) reduced to ₹25.6 crores as of June 30, 2026, from ₹28.2 crores as of March 31, 2026, and fixed deposits stood at ₹300 crores.
Doctor Retention and Talent Management
Park Medi World maintains a low attrition rate at the consultant level, attributing it to their unique model where doctors are treated as partners, not just employees. The focus is on patient and attendant satisfaction and high-end clinical outcomes, rather than revenue targets. This approach, combined with competitive pay and ESOPs, helps attract and retain talent, even in Tier-2 and Tier-3 cities, by offering freedom and recognition.
Payer Mix Evolution and Quality Accreditations
The current payer mix for Q1 FY27 was approximately 77% from government insurance schemes and 23% from self-pay, private insurance, and TPA. The company aims to shift this mix to a 70:30 split (government:cash/TPA) over the next 12-18 months. All operational hospitals are NABH-accredited, and the recently commissioned Panchkula facility is progressing through its NABH accreditation. The company plans to obtain NABL accreditation for four additional labs in the current financial year, adding to the existing nine.